« Gene Therapy Products in Development » – Breakdown by type of product and Breakdown by therapeutic area (Updated Nov 2019) – An Overview of more than 580 gene therapy products already in clinical trials or at the discovery/preclinical stage
More than 580 gene therapy products are under development in biotech and pharmaceutical companies for the treatment of more than 240 diseases. More than 200 of these products are now at the clinical stage.
After releasing our « Landscape in… Gene Therapy Companies » in September, BioPharmAnalyses and Octopusyx BioConsulting are now offering you an opportunity to get a global overview of these gene therapy programs whether they are at the clinical or at the discovery/preclinical stage.
This new report entitled « Gene Therapy Products in Development » (Updated Nov 2019) will provide you an accurate breakdown of these programs:
– by type of product (AAV-based products, lentiviral-based products, antisense products, mRNA, RNAi/siRNA, miRNA, gene editing products….)
– by therapeutic area (autoimmune diseases, cancers, cardiovascular diseases, hematological diseases, immunological diseases, lysosomal diseases, CNS diseases, ophthalmological diseases…).
This 220-pages report presents a comprehensive view of more than 580 products (type of product, development phase, indication, company). It includes synthetic figures showing global and detailed breakdown by development stage and by therapeutic area.
Please click here to get sample pages of « Gene Therapy Products in Development » Breakdown by type of product – Breakdown by therapeutic area.
Please click here to get order form and buy « Gene Therapy Products in Development » Breakdown by type of product – Breakdown by therapeutic area.